Abstract
This study reports the isolation of two novel cysteine-rich antibacterial peptides, turgencin A and turgencin B, along with their oxidized derivatives, from the Arctic marine colonial ascidian Synoicum turgens. The peptides are post-translationally modified, containing six cysteines with an unusual disulfide connectivity of Cys(1)-Cys(6), Cys(2)-Cys(5), and Cys(3)-Cys(4) and an amidated C-terminus. Furthermore, the peptides contain methionine residues resulting in the isolation of peptides with different degrees of oxidation. The most potent peptide, turgencin A(Mox1) with one oxidized methionine, displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria with a minimum inhibitory concentration (MIC) as low as 0.4 µM against selected bacterial strains. In addition, the peptide inhibited the growth of the melanoma cancer cell line A2058 (IC(50) = 1.4 µM) and the human fibroblast cell line MRC-5 (IC(50) = 4.8 µM). The results from this study show that natural peptides isolated from marine tunicates have the potential to be promising drug leads.